Potential use of exenatide for the treatment of obesity

Author： Folli Franco Guardado Mendoza Rodolfo

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.12, 2011-12, pp. : 1717-1722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics: potential role in the treatment of diabetes and obesity

By Vella Adrian Camilleri Michael

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1109-1119

Informa Healthcare

Access to resources Recommend Favorite

Nicotine, Body Weight and Potential Implications in the Treatment of Obesity

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 8, 2003-05 ,pp. : 899-919

Bentham Science Publishers

Access to resources Recommend Favorite

GPR 120: The Potential Target for Obesity Treatment

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. : 8-11

Bentham Science Publishers

Access to resources Recommend Favorite

Exenatide

By Keating Gillian M.

Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. : 1681-1692

Adis International

Access to resources Recommend Favorite

Use of exenatide and liraglutide in Denmark: a drug utilization study

By Pottegård Anton Bjerregaard Bine Larsen Michael Larsen Kasper Hallas Jesper Knop Filip Moreno Søren

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 205-214

Springer Publishing Company

Access to resources Recommend Favorite